A Kentucky smelter becomes a data-center site. A new one is planned for Oklahoma. At Century Aluminum, the electricity deal helps decide what gets built next.
The company that helped turn aluminum into an everyday material is trying to change its chemistry again. This time, the hard part is cutting carbon without losing the economics that made the metal useful.

He spent a decade keeping Alcoa’s financial score. Now Bill Oplinger is putting his engineering and operating experience behind a larger bet on the journey from mine to metal.
Rui Jing Jiang is the Founder and CEO of Avisi Technologies, a Redwood City-based clinical-stage medical device company developing VisiPlate, the world's thinnest freestanding ophthalmic implant for treating glaucoma. Built on University of Pennsylvania nanotechnology, VisiPlate is a multichannel aqueous shunt composed of alumina and Parylene-C that is 20 times thinner than a human hair. Rui Jing co-founded the company in 2017 as a junior at Penn's Wharton School, won the $100,000 President's Innovation Prize in 2018, secured FDA Investigational Device Exemption approval in October 2025 for the US SAPPHIRE trial, and closed a $10.7M Series A in February 2026 to advance pivotal clinical development.